I'm assuming it will be similar to a stroke trial, presumably the primary gauge of efficacy will be MRIs or ECGs to monitor either decreases in infarct volume, improvements in any penumbral areas,or improvement in brain activity. The stroke trials run by Clinuvel and Argenica don't use control groups, they gauge improvement over SoC with MRIs.
NEU Price at posting:
$12.01 Sentiment: Buy Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)